Progress Updates
April 1, 2020
Research News Roundup–March 2020
Even though it’s April Fool’s Day, the stories we share in this monthly column are no joke. Because since last month our world has shifted focus, we’ve divided these releases into two sections – COVID-related, and everything else. “Everything else” is at the end this month, because it is the bigger section, with nearly a […]
Tags: AFib, Alzheimer's disease, anesthesiology, cardiology, cardiovascular medicine, clinical trials, COVID-19, Department of Laboratory Medicine and Pathology, FDA, Fredric Meyer, heart attack, heart disease
March 24, 2020
By Susan Murphy 
By Sharon Rosen Patients suffering from depression, anxiety and substance use disorders often search for years to find treatment. Studies have shown that during this time gap, patients’ symptoms worsen, increasing their risk for other chronic illnesses, shortened lifespan and poor quality of life. Mayo Clinic statistical geneticist Joanna Biernacka, Ph.D. and her colleagues are working to […]
Tags: anxiety, biobank, Center for Individualized Medicine, depression, genetic testing, genetics, Joanna Biernacka, Mark Frye, psychiatry, substance abuse disorder
February 27, 2020
Evolution of cardiac regeneration
February is American Heart Month, a time to acknowledge advancements in a new generation of care. This year focus is placed on repairing damaged heart tissue and restoring heart function after a heart attack. The Mayo Clinic Center for Regenerative Medicine is leading research into cardiac regeneration. Accounting for nearly 20 million of all deaths, heart […]
Tags: Atta Behfar, biomedical research, cardiac regeneration, cardiology, cardiovascular disease, Center for Regenerative Medicine, discovery research, heart attack, heart disease, Michael Sabbah
December 30, 2019
Research highlights from Florida – fruitful in 2019
By Advancing the Science contributor
Florida sunshine doesn’t just contribute to big, juicy oranges. In 2019, Florida was a hotbed of growth for Mayo Clinic Research, with 11.8% more funding leading to new capabilities such as ex vivo perfusion for lungs – leading to more available for transplant, and carbon ion therapy for cancer – currently not available to patients in the U.S. Read on for more on these and other practice transforming activities.
Tags: artificial intelligence, biopsy, breast cancer, cancer, cancer vaccine, carbon ion therapy, Center for Individualized Medicine, clinical trials, ex vivo lung perfusion, immunology, Keith Knutson, lung cancer
October 23, 2019
With growing public awareness and broader academic engagement, the prospect of pioneering a change in disease management has propelled the field of regenerative medicine. The ability to build, scale and apply biotherapeutic technologies and solutions that are not cost prohibitive will become increasingly important elements that drive progress in regenerative medicine. In a recently published paper, […]
Tags: Andre Terzic, Atta Behfar, biomanufacturing, Center for Regenerative Medicine, stem cells
October 16, 2019
Advances in IBS Research Target Dietary Burdens
By Advancing the Science contributor
By Sara Nick The number one reason to miss school or work in the U.S. is the common cold. Number two? Irritable bowel syndrome (IBS), a disorder of the large intestine that can cause cramping, pain, gas, constipation, and diarrhea. “IBS is incredibly prevalent, affecting about 1 in 7 adults,” says Mayo Clinic gastroenterologist […]
Tags: Brian Lacy, gastroenterology, gut health, IBS, irritable bowel syndrome
October 14, 2019
BEAUTY Update: Progress in breast cancer research
By Advancing the Science contributor
By Barbara J. Toman Chemotherapy is a standard breast cancer treatment, used for aggressive biology breast cancer to shrink tumors in the breast and lymph nodes before surgery, assess response and destroy any undetected cancer cells elsewhere in the patient. But some breast tumors don’t respond well to chemotherapy, putting patients at high risk of […]
Tags: breast cancer, cancer, Center for Individualized Medicine, chemotherapy, clinical trials, genetics, genomics, individualized medicine, Judy Boughey, Liewei Wang, Matthew Goetz, Mayo Clinic Cancer Center
September 26, 2019
Bioartificial liver: Bridge to liver regeneration
The liver has the greatest regenerative capacity of any organ in the body. However, when the liver is injured beyond its ability to regenerate itself, and a transplant is not readily available, there are few options for patients. Led by Scott Nyberg, M.D., Ph.D., researchers are refining their own version of a bioartificial liver, known as […]
Tags: bioartificial liver, Center for Regenerative Medicine, regenerative medicine, research, Scott Nyberg, stem cells, transplant
September 24, 2019
Research for infants with HLHS moves forward
Hypoplastic left heart syndrome (HLHS) is a complex and rare heart defect present at birth in which the left side of a child’s heart is severely underdeveloped. At Mayo Clinic, physicians and researchers in the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome are looking for ways to delay or even prevent heart failure for […]
Tags: Center for Regenerative Medicine, clinical trials, HLHS, hypoplastic left heart syndrome, pediatric cardiology, stem cells
September 12, 2019
Behind the scenes–Mayo Clinic Research
Everything health care has to offer for patients is the result of research and education related to that research. At Mayo Clinic, research drives everything we do, resulting in evidence-based treatments and continuous improvements in the way patients, caregivers and others experience health care. At Mayo Clinic we share information about our programs and projects […]
Tags: biomedical ethics, CAR-T, cardiology, cellular therapy, clinical trials, dialysis, Ian Lanza, Januario Castro, kidney disease, medical research, metabolism, neurology